Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Ca ...
Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, multicenter, registrational Phase III HARMONi-GI1 trial (AK112-309). The study ...
ESPN's NFL depth charts for the 2026 season are updated throughout the year with the latest news, updates and intel from across the league.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results